Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05816694
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-04-18
First Post:
2023-03-27
Brief Title:
The Efficacy and Safety of Nanoparticle Albumin-bound NAB-Paclitaxel Plus Cisolation Versus CEP Cisplatin EpirubicinCyclophosphamide in Induction Therapy for Thymoma a Study for a Single-center Prospective Phase II Randomized Controlled Train
Sponsor:
Organization:
Shanghai Zhongshan Hospital